Anvisa Board of Directors Resolution No. 982, July 28, 2025
"Art. 1. This Resolution establishes the use of health risk management criteria and compliance monitoring for companies for the initial granting or renewal of the Good Manufacturing Practices Certificate (CBPF) and the Good Distribution and/or Storage Practices Certificate (CBPDA) for establishments that manufacture, distribute, and store active pharmaceutical ingredients (APIs), medications, cannabis products for medicinal purposes, biological products, and medical devices."